دورية أكاديمية
COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population
العنوان: | COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population |
---|---|
المؤلفون: | Narmeen Mallah, Jacobo Pardo-Seco, Irene Rivero-Calle, Ouhao Zhu-Huang, María Fernández Prada, Catharina Reynen-de Kat, Oleg Benes, Liudmila Mosina, Siddhartha Sankar-Datta, Olga Aleksinskaya, David Díaz, Vusala Allahverdiyeva, Yevgenii Grechukha, Tamara Jobava, Mariia Savchyna, Pavla Kortusova, Ioana Novac, Federico Martinón-Torres |
المصدر: | Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024) |
بيانات النشر: | Taylor & Francis Group, 2024. |
سنة النشر: | 2024 |
المجموعة: | LCC:Immunologic diseases. Allergy LCC:Therapeutics. Pharmacology |
مصطلحات موضوعية: | COVID-19, COVID-19 InfoVaccines, educational tool, Europe, misinformation, World Health Organization, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950 |
الوصف: | ABSTRACTCOVID-19 vaccine uptake varied across countries, in part due to vaccine hesitancy fueled by a lack of trustworthy information. To help health workers provide evidence-based answers to common questions about COVID-19 vaccines and vaccination, and thereby, assist individuals´ decisions on vaccine acceptance, COVID-19 InfoVaccines, a joint WHO-EU project, was launched in February 2021 to support COVID-19 vaccine rollout in 6 Eastern European countries. COVID-19 InfoVaccines was made available in seven languages and shared on social media networks. A total of 262,592 users accessed COVID-19 InfoVaccines.com between February 11, 2021, and January 31st, 2023. The users were most interested in: general questions; vaccine efficacy and duration of protection; vaccine safety; vaccine co-administration, and dose-interval and interchangeability; though the interest in a specific theme varied in function of the epidemiological situation. A total of 118,510 (45.1%) and 46,644 (17.7%) users scrolled up to 35% and 75% of the COVID-19 InfoVaccines webpage, respectively. The average engagement rate was 71.61%. The users accessed COVID-19 InfoVaccines from 231 countries and territories, but the majority were in Ukraine (N = 38,404; 14.6%), Spain (N = 23,327; 8.9%), and Argentina (N = 21,167; 8.1%). Older Facebook users were more interested in COVID-19 information than younger individuals (X2 p-value < .0001). Two hundred twenty-eight videos were shared on YouTube. The average Click-Through-Rate on Facebook was 7.82%, and that on YouTube was 4.4%, with 60 videos having a Click-Through-Rate >5%, falling in the range of average YouTube video Click-Through-Rate (2% – 10%). As misinformation about vaccines and vaccination spreads easily and can negatively impact health-related decisions, initiatives like COVID-19 InfoVaccines are crucial to facilitate access to reliable information. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 21645515 2164-554X 2164-5515 |
Relation: | https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X |
DOI: | 10.1080/21645515.2024.2350817 |
URL الوصول: | https://doaj.org/article/9f69d43e3ef945de90db22c95351b089 |
رقم الأكسشن: | edsdoj.9f69d43e3ef945de90db22c95351b089 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 21645515 2164554X |
---|---|
DOI: | 10.1080/21645515.2024.2350817 |